← Back to headlines
Argenx to Acquire Forte in $2.2 Billion Deal for Immune Drug
Argenx has announced its intention to acquire Forte in a $2.2 billion deal. The acquisition is focused on obtaining a 'differentiated' immune drug.
27 Jul, 11:46 — 27 Jul, 11:46
Sources
Showing 1 of 1 sources
